High-Density Lipoprotein-Associated Paraoxonase 1: A Possible Prognostic Biomarker for Heart Failure?

European Journal of Heart Failure - United States
doi 10.1002/ejhf.817
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley-Blackwell

Related search

High-Density Lipoprotein: NO Failure in Heart Failure

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2013English

Rabbit Serum Paraoxonase 3 (PON3) Is a High Density Lipoprotein-Associated Lactonase and Protects Low Density Lipoprotein Against Oxidation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Indications That Paraoxonase-1 Contributes to Plasma High Density Lipoprotein Levels in Familial Hypercholesterolemia

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2004English

High-Density Lipoprotein Composition and Paraoxonase Activity in Type I Diabetes

Clinical Science
Medicine
2001English

High Density Lipoprotein (Α Lipoprotein) in Ischemic Heart Disease

The Journal of Japan Atherosclerosis Society
1979English

Improving Heart Function by Modulating Myocardiocyte Autophagy: A Possible Novel Mechanism for Cardiovascular Protection of High-Density Lipoprotein

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2014English

Metrics of High-Density Lipoprotein Function and Hospital Mortality in Acute Heart Failure Patients

PLoS ONE
Multidisciplinary
2016English

Is High-Density Lipoprotein a Modifiable Treatment Target or Just a Biomarker for Cardiovascular Disease?

JRSM Cardiovascular Disease
2019English

Bile Acids Decrease Hepatic Paraoxonase 1 Expression and Plasma High-Density Lipoprotein Levels via FXR-Mediated Signaling of FGFR4

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy